Back
Sypris Solutions 10K Form
Buy
65
SYPR
Sypris Solutions
Last Price:
$1.88
Seasonality Move:
6.99%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-15 | 10Q | SYPR/Sypris Solutions Quarterly |
2023-11-15 | 10Q | SYPR/Sypris Solutions Quarterly |
2023-08-15 | 10Q | SYPR/Sypris Solutions Quarterly |
2023-05-16 | 10Q | SYPR/Sypris Solutions Quarterly |
2022-11-16 | 10Q | SYPR/Sypris Solutions Quarterly |
2022-08-16 | 10Q | SYPR/Sypris Solutions Quarterly |
Receive SYPR News And Ratings
See the #1 stock for the next 7 days that we like better than SYPR
SYPR Financial Statistics
Sales & Book Value
Annual Sales: | $136.2M |
---|---|
Cash Flow: | $-4.9M |
Price / Cash Flow: | 0 |
Annual Sales: | $0.79 |
Price / Book: | 2.64 |
Profitability
EPS (TTM): | -0.12930 |
---|---|
Net Income (TTM): | $-2.9M |
Gross Margin: | $17.2M |
Return on Equity: | -14.2% |
Return on Assets: | -2.28% |
Sypris Solutions Earnings Forecast
Key Sypris Solutions Financial Ratios
-
The Gross Profit Margin over the past 30 years for SYPR is 12.66%.
-
The Selling, General & Administrative Expenses for SYPR have been equal to 11.95% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is -48.68% of Operating Income.
-
The Net Earning history of SYPR is -1.17% of Total Revenues.
-
Per Share Earnings over the last 30 years have been positive in 14 years.
Sypris Solutions Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Automobile Components |
Sector: | Consumer Discretionary |
Current Symbol: | SYPR |
CUSIP: | 871655 |
Website: | sypris.com |
Debt
Debt-to-Equity Ratio: | 0.6 |
---|---|
Current Ratio: | 1.26 |
Quick Ratio: | 0.26 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
SYPR Technical Analysis vs Fundamental Analysis
Buy
65
Sypris Solutions (SYPR)
is a Buy
Is Sypris Solutions a Buy or a Sell?
-
Sypris Solutions stock is rated a BuyThe current Sypris Solutions [SYPR] share price is $2.08. The Score for SYPR is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.